EST
IRWD icon

EA Series Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

EA Series Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$196K Buy
+18,407
New +$198K 0.01% 1078

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EA Series Trust's IRWD Position: Q2 2023 in Review

EA Series Trust opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2023: 18,407 shares worth $196K. The stake represents 0.01% of the portfolio and ranks #1078 among its holdings.

252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

  • EA Series Trust held 18,407 shares of Ironwood Pharmaceuticals worth $196K as of Q2 2023.
  • Ironwood Pharmaceuticals was a new EA Series Trust position in Q2 2023.
  • Ironwood Pharmaceuticals made up 0.01% of EA Series Trust's portfolio in Q2 2023, its #1078 holding.
  • 252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.